Financial News
Articles published by Relief Therapeutics Holdings AG
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office
February 08, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Topics
Death
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Comments on Lawsuit Filed Against It by NeuroRx
January 12, 2022
Via AccessWire
Topics
Lawsuit
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Topics
Lawsuit
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA
January 03, 2022
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Launches Level 1 ADR Program in the United States
November 18, 2021
Via AccessWire
Exposures
COVID-19
Tickers
RLFTF
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Announces Transitions in Commercial Organization to Implement Next Phase of Corporate Development
November 09, 2021
Via AccessWire
Topics
Intellectual Property
Tickers
RLFTF
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.